Company: BAYAU
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001641172-25-002125
Chunk: 363

Company: Bayview Acquisition Corp
Filing Date: 2025-04-01
Form: 10-K
Item: Item 1B
Chunk 363
---
 to our Sponsors (the “Promissory Note”), pursuant to which we received
proceeds of $300,000 to cover expenses related to the initial public offering. The Promissory Note was non-interest bearing and payable
on the earlier of (i) December 31, 2023, or (ii) the consummation of the IPO. The Promissory Note expired after the consummation of the
IPO.

Transaction
costs related to the issuances described above amounted to $4,341,321, consisting of $1,200,000 of cash underwriting fees, $2,100,000
of deferred underwriting fees and $1,041,321 of other offering costs. After deducting the underwriting discounts and commissions and
offering expenses, the total net proceeds from the initial public offering and the sale of the Private Placement Units $60,000,000 (or
$10.00 per share sold in the initial public offering) was placed in the Trust Account.

Redemptions

In
connection with the vote to approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal at the Extraordinary
General Meeting held on September 16, 2024, the holders of 2,290,989 Ordinary Shares properly exercised their rights to redeem their shares for cash at a
redemption price of approximately $10.39 per share, for an aggregate redemption amount of approximately $23,803,376.

    Item
    6.
    [Reserved]

  73 

    Item
    7.
    Management’s
    Discussion and Analysis of Financial Condition and Results of Operations

References
to the “Company,” “our,” “us” or “we” refer to Bayview Acquisition Corp. The following
discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the audited
financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data”
of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.
Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results
may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth
under “Cautionary Note Regarding Forward-L